Regenerative therapy is a cellular-level therapy that aims to improve the function of damaged or diseased tissue or organs by introducing cells to replace or repair damaged cells. Today, regenerative therapies are being recognized for their therapeutic potential for a wide variety of medical conditions across a range of specialties, including orthopedics, rheumatology, cardiology, neurology, immunology, and much more.
Because of their ability to differentiate into cells that carry out the roles needed in a variety of bodily functions; cellular allografts are an essential regenerative tool. When these allografts are introduced into damaged tissue or organ, they have the ability to evolve and carry out necessary functions, repairing or compensating for the damaged cells. As a minimally invasive process, regenerative therapy harnesses the natural capabilities of regenerative allografts and the body’s own ability to heal, providing an opportunity to avoid painful and invasive procedures.
Scope of Regenerative Therapy
Cell allografts, that occur naturally in the body, are “naive” or unspecialized. This means that, based on cues from their environment, these cells have the ability to transform into and assume the functions of a variety of different cells and cell types in the body. The ability to mature in a context-specific way is the key to the vast potential of cells in regenerative therapies. When introduced into damaged tissue, the cells can specialize and carry out their necessary functions in that particular area, potentially improving symptoms and function.
While regenerative cells are found throughout the body, the cells used in medicine today may be derived from four different sources: umbilical cord tissue, embryonic tissue, bone marrow aspirate, and adipose tissue. However, some sources have their drawbacks. Embryonic cells raise ethical concerns, while bone marrow and adipose tissue-derived products can only be retrieved through invasive surgical procedures and have a significantly lower yield.
Considering this, BioGenix uses exclusively umbilical cord-derived products. Umbilical cord tissue retrieval, which takes place immediately after the umbilical cord is cut upon delivery, is non-invasive and ethically sound. In addition, umbilical cord tissue products have the highest product yield and are the best source of growth factors and cytokines that have an important role in regenerative therapies.